Cagrilintide/semaglutide
RAMBO
Novo Nordisk · Phase 1 · Recruiting · Enrollment 144
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cagrilintide | Obesity or overweight | n/r | 79 | n/r | n/r |
| Semaglutide | Obesity or overweight | n/r | 79 | n/r | n/r |
| CagriSema | Obesity or overweight | n/r | 79 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 79 | n/r | n/r |